Literature DB >> 20954976

Ischemic nephropathy: proteinuria and renal resistance index could suggest if revascularization is recommended.

Rosario Cianci1, Paola Martina, Matteo Cianci, Raffaella Lavini, Gilda Stivali, Domenico Di Donato, Lelio Polidori, Silvia Lai, Roberta Renzulli, Antonietta Gigante, Biagio Barbano.   

Abstract

BACKGROUND: The aim of endovascular therapy in renal artery stenosis (RAS) is to preserve renal function and have a better hypertension control. The purpose of our study was to determine which biochemical and instrumental parameters could predict a better renal outcome in patients with RAS treated with percutaneous transluminal angioplasty and stenting (RPTAS).
METHODS: We performed an observational study based on 40 patients with RAS who met the following criteria before revascularization: urinary protein excretion of over 250 mg/24 h, normal renal function, and/or mild-moderate renal insufficiency (I, II, and III levels of classification of chronic kidney disease, K-DOQI).
RESULTS: Assessment at 12 months after RPTAS showed in 20 patients (Group A) that proteinuria serum creatinine (Scr) and creatinine clearance (CrCl) significantly worsened from the baseline; whereas in 20 patients (Group B) proteinuria remained unchanged and the renal function improved after the procedure.
CONCLUSIONS: In our study, the decline of renal function after RPTAS is associated with an elevated renal resistance index (RI) in both kidneys (0.83 ± 0.2) and preexisting proteinuria.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20954976     DOI: 10.3109/0886022X.2010.516856

Source DB:  PubMed          Journal:  Ren Fail        ISSN: 0886-022X            Impact factor:   2.606


  6 in total

1.  Renal parenchymal resistance in patients with biopsy proven glomerulonephritis: Correlation with histological findings.

Authors:  Antonietta Gigante; Biagio Barbano; Francesca Di Mario; Edoardo Rosato; Marzia Simonelli; Anna Rachele Rocca; Fabrizio Conti; Fulvia Ceccarelli; Konstantinos Giannakakis; Guido Valesini; Rosario Cianci
Journal:  Int J Immunopathol Pharmacol       Date:  2016-04-18       Impact factor: 3.219

2.  Mortality and Renal Replacement Therapy after Renal Artery Stent Placement for Atherosclerotic Renovascular Disease.

Authors:  Sanjay Misra; Ankaj Khosla; Jake Allred; William S Harmsen; Stephen C Textor; Michael A McKusick
Journal:  J Vasc Interv Radiol       Date:  2016-06-11       Impact factor: 3.464

Review 3.  Renal resistive index as a marker of vascular damage in cardiovascular diseases.

Authors:  Arkadiusz Lubas; Grzegorz Kade; Stanisław Niemczyk
Journal:  Int Urol Nephrol       Date:  2014-02       Impact factor: 2.370

4.  Evaluation of the diagnostic value of the renal resistive index as a marker of the subclinical development of cardiorenal syndrome in MMVD dogs.

Authors:  Barbara Szczepankiewicz; Urszula Pasławska; Natalia Siwińska; Krzysztof Plens; Robert Pasławski
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2021 Jan-Dec       Impact factor: 1.636

5.  Predictive role of renal resistive index for clinical outcome after revascularization in hypertensive patients with atherosclerotic renal artery stenosis: a monocentric observational study.

Authors:  Rosa Maria Bruno; Elena Daghini; Daniele Versari; Melania Sgrò; Michela Sanna; Luigi Venturini; Caterina Romanini; Irene Di Paco; Isabella Sudano; Roberto Cioni; Lilach O Lerman; Lorenzo Ghiadoni; Stefano Taddei; Stefania Pinto
Journal:  Cardiovasc Ultrasound       Date:  2014-02-20       Impact factor: 2.062

6.  Hyperaldosteronism and cardiovascular risk in patients with autosomal dominant polycystic kidney disease.

Authors:  Silvia Lai; Luigi Petramala; Daniela Mastroluca; Emanuela Petraglia; Alessandro Di Gaeta; Elena Indino; Valeria Panebianco; Mauro Ciccariello; Hossein H Shahabadi; Alessandro Galani; Claudio Letizia; Anna Rita D'Angelo
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.